Literature DB >> 24476004

Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.

Wen-Yong Wu1, Hyunchul Kim, Chang-Le Zhang, Xiang-Ling Meng, Zheng-Sheng Wu.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers with a high mortality rate. Constitutive activation of STAT3 is found in various types of tumors, including HCC. In addition, suppressors of cytokine signaling 3 (SOCS3) signals for negative feedback to STATs, and is found to be inversely correlated with STAT3 expression. However, the exact role of SOCS3 in the tumorigenesis and progression of HCC is not fully understood. In this study we intended to show that SOCS3 inhibition promotes proliferation, migration, and invasion of HCC cells. HepG2, a human HCC cell line, was grown with SOCS3 siRNA or negative control (NC) transfection to assess the involvement of SOCS3 in cell proliferation, migration, and invasion by MTT, migration, and invasion assays, respectively. Western blot analysis was performed to examine the expression of STAT3, SOCS3, c-myc, matrix metalloproteinase (MMP)-2, and MMP-9 after transfection with either SOCS3 or NC siRNAs. A diethylnitrosamine (DEN)-induced HCC mouse model was assessed with or without injection of NSC 74859, a STAT3 inhibitor, to show accompanied changes among the expressions of STAT3, SOCS3, c-myc, MMP-2, and MMP-9. Inhibition of SOCS3 expression promoted the proliferation, migration, and invasion of HepG2 cells and increased the expression of c-myc, MMP-2, and MMP-9. HCC tumors developed in mice by DEN-induction with administration of NSC 74859 resulted in decreased expression of c-myc, MMP-2, and MMP-9, but not SOCS3. Loss of SOCS3 increased tumor growth, migration, and invasion and resulted in accompanied changes in expression of STAT3 and its target oncoproteins.

Entities:  

Keywords:  SOCS3; STAT3; hepatocellular carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24476004     DOI: 10.3109/08941939.2013.873098

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  7 in total

1.  The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.

Authors:  Meiling Cui; Ji Sun; Jianjing Hou; Tao Fang; Xin Wang; Chao Ge; Fangyu Zhao; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li; Hong Li
Journal:  Tumour Biol       Date:  2016-07-28

2.  SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.

Authors:  Xin Zhang; Qingshan You; Xiaolei Zhang; Xiangmei Chen
Journal:  Int J Mol Sci       Date:  2015-09-18       Impact factor: 5.923

3.  Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Authors:  Minqian Shen; Haifei Shi
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

4.  To Explore the Molecular Mechanism of Acupuncture Alleviating Inflammation and Treating Obesity Based on Text Mining.

Authors:  YiKuan Du; LuLu He; XinNi Ye; ShuZhen Chen; GuanHao Li; YuanWei Yu; ErBai Ye; YiXing Huang; YuQi Zhou; WeiChui Zhang; Chun Yang
Journal:  Biomed Res Int       Date:  2022-09-05       Impact factor: 3.246

Review 5.  Regulation of Natural Killer Cell Function by STAT3.

Authors:  Nicholas A Cacalano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

6.  FXR induces SOCS3 and suppresses hepatocellular carcinoma.

Authors:  Fei Guo; Zhizhen Xu; Yan Zhang; Peng Jiang; Gang Huang; Shan Chen; Xilin Lyu; Ping Zheng; Xin Zhao; Yijun Zeng; Shuguang Wang; Fengtian He
Journal:  Oncotarget       Date:  2015-10-27

7.  Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.

Authors:  Li Huang; Bin Hu; Jianbo Ni; Jianghong Wu; Weiliang Jiang; Congying Chen; Lijuan Yang; Yue Zeng; Rong Wan; Guoyong Hu; Xingpeng Wang
Journal:  J Exp Clin Cancer Res       Date:  2016-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.